Friday, November 22, 2024
HomeTagsAnaphylactic

anaphylactic

Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, participated in U.S. Food and Drug Administration (FDA) Vaccines and Related...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics